World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
43810
World Ranking
7007
National Ranking
74

Xin Yuan Guan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Xin Yuan Guan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 625 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Xin Yuan Guan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Xin Yuan Guan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

Xin Yuan Guan spends much of his time researching Cancer research, Metastasis, Pathology, Cancer and Molecular biology. Xin Yuan Guan studies Hepatocellular carcinoma, a branch of Cancer research. His Metastasis research includes themes of Cell migration, Oncology, Messenger RNA, microRNA and Vimentin.

His studies in Pathology integrate themes in fields like Epithelial–mesenchymal transition, Cell and In vivo. His biological study deals with issues like Downregulation and upregulation, which deal with fields such as Colorectal cancer. Xin Yuan Guan combines subjects such as Genetics, Fluorescence in situ hybridization, Chromosome, Chromosome microdissection and Gene duplication with his study of Molecular biology.

His most cited work include:

  • Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer (2028 citations)
  • AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer (1526 citations)
  • Identification and characterization of tumorigenic liver cancer stem/progenitor cells. (956 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Cancer research, Cancer, Metastasis, Pathology and Hepatocellular carcinoma. His research integrates issues of Cell growth, Carcinogenesis, Cancer stem cell, Downregulation and upregulation and Oncogene in his study of Cancer research. His study in Carcinogenesis is interdisciplinary in nature, drawing from both Molecular biology and Cell cycle.

His Cancer research is multidisciplinary, incorporating perspectives in microRNA and Oncology. His studies in Metastasis integrate themes in fields like Cell, Angiogenesis, Ectopic expression, Signal transduction and Regulation of gene expression. His study in Immunohistochemistry and Carcinoma is carried out as part of his studies in Pathology.

He most often published in these fields:

  • Cancer research (76.88%)
  • Cancer (30.00%)
  • Metastasis (28.91%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (76.88%)
  • Metastasis (28.91%)
  • Hepatocellular carcinoma (22.81%)

In recent papers he was focusing on the following fields of study:

Xin Yuan Guan mainly investigates Cancer research, Metastasis, Hepatocellular carcinoma, Cell growth and Downregulation and upregulation. The concepts of his Cancer research study are interwoven with issues in Cancer, Tumor progression, Gene knockdown, Ectopic expression and Kinase. His work carried out in the field of Metastasis brings together such families of science as Osteosarcoma, Angiogenesis, Chromosomal translocation, Regulation of gene expression and Colorectal cancer.

His research in Hepatocellular carcinoma intersects with topics in Transcriptome, Stem cell and In vivo. The various areas that Xin Yuan Guan examines in his Cell growth study include Protein kinase B, Carcinogenesis, RNA, Gene silencing and Programmed cell death. His Downregulation and upregulation research is multidisciplinary, relying on both Chemoradiotherapy, Chemotherapy, Cancer cell, microRNA and PI3K/AKT/mTOR pathway.

Between 2018 and 2021, his most popular works were:

  • N 6 -methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis (99 citations)
  • N 6 -methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis (99 citations)
  • APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production (56 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

His primary scientific interests are in Cancer research, Metastasis, Downregulation and upregulation, Cell growth and Cancer cell. His Cancer research research focuses on Hepatocellular carcinoma in particular. His work deals with themes such as Angiogenesis, Carcinoma, Cell adhesion molecule, Loss of heterozygosity and Colorectal cancer, which intersect with Metastasis.

His research in Downregulation and upregulation focuses on subjects like Gene knockdown, which are connected to Oncogene, LRP6, Caveolin 1 and HBx. The study incorporates disciplines such as Lymphoid enhancer-binding factor 1, Receptor, Notch signaling pathway and HCCS in addition to Cell growth. His research investigates the connection with Cancer cell and areas like Cancer stem cell which intersect with concerns in PI3K/AKT/mTOR pathway, Cancer-Associated Fibroblasts, Crosstalk, Computational biology and Exosome.

Best Publications

  • Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

    Fredrick S. Leach;Nicholas C. Nicolaides;Nickolas Papadopoulos;Bo Liu

  • AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer

    Sarah L. Anzick;Juha Kononen;Robert L. Walker;David O. Azorsa

  • Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

    Stephanie Ma;Kwok–Wah Chan;Liang Hu;Terence Kin–Wah Lee

  • Comparative analyses of multi-species sequences from targeted genomic regions

    J. W. Thomas;J. W. Thomas;J. W. Touchman;R. W. Blakesley;G. G. Bouffard

  • Genomic instability in laminopathy-based premature aging

    Baohua Liu;Jianming Wang;Kui Ming Chan;Wai Mui Tjia

  • Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations

    Stephanie Ma;Kwok Wah Chan;Terence Kin-Wah Lee;Kwan Ho Tang

  • N 6 -methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis

    Ri-Xin Chen;Xin Chen;Liang-Ping Xia;Jia-Xing Zhang

  • Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma

    Leilei Chen;Yan Li;Chi Ho Lin;Tim Hon Man Chan;Tim Hon Man Chan

  • Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition

    Terence K. Lee;Ronnie T.P. Poon;Anthony P. Yuen;Ming Tat Ling

  • miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1

    Stephanie Ma;Kwan Ho Tang;Yuen Piu Chan;Terence K. Lee

  • The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

    Fang Zheng;Yi Ji Liao;Mu Yan Cai;Yan Hui Liu

  • A targeted disruption of the murine Brca1 gene causes γ-irradiation hypersensitivity and genetic instability

    Shan Xiang Shen;Zoë Weaver;Xiaoling Xu;Cuiling Li

  • Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma

    Oscar W.H. Yeung;Chung Mau Lo;Chang Chun Ling;Xiang Qi

  • Rapid generation of region specific probes by chromosome microdissection and their application.

    Paul S. Meltzer;Xin Yuan Guan;Ann Burgess;Jeffrey M. Trent

  • MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression†‡

    Jian Hong Fang;Hui Chao Zhou;Chunxian Zeng;Jine Yang

  • Association of Vimentin overexpression and hepatocellular carcinoma metastasis

    Liang Hu;Sze Hang Lau;Chi Hung Tzang;Jian Ming Wen

  • Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.

    Terence Kin-Wah Lee;Xin-Yuan Guan;Xin-Yuan Guan;Stephanie Ma;Stephanie Ma

  • CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling†‡

    Kwan Ho Tang;Stephanie Ma;Terence K. Lee;Yuen Piu Chan

  • MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor

    Kar Lok Kong;Dora Lai Wan Kwong;Tim Hon Man Chan;Simon Ying Kit Law

  • Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1

    Stephanie Ma;Kwan Ho Tang;Yuen Piu Chan;Terence K. Lee

Frequent Co-Authors

Dan Xie
Dan Xie Sun Yat-sen University
Stephanie Ma
Stephanie Ma University of Hong Kong
Yi Xin Zeng
Yi Xin Zeng Sun Yat-sen University
Jonathan S.T. Sham
Jonathan S.T. Sham University of Hong Kong
Yan Li
Yan Li Sun Yat-sen University
Sai Wah Tsao
Sai Wah Tsao University of Hong Kong
Hsiang-Fu Kung
Hsiang-Fu Kung Chinese University of Hong Kong
Jeffrey M. Trent
Jeffrey M. Trent Translational Genomics Research Institute
Paul S. Meltzer
Paul S. Meltzer National Institutes of Health
Simon Law
Simon Law University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking flexible alternatives to traditional programs, many options exist online. Careers in healthcare are diverse and rapidly growing, with roles that support clinical teams or focus on specialized fields. Accredited online degrees and certifications make it easier to balance studies with other responsibilities, while still accessing quality education.

For those looking into pharmacy, online pharmacy programs offer a pathway to a clinical or research-focused career. Alternatively, a health information management bachelor degree online equips you to manage patients' health records and data in a rapidly digitizing field.

Shorter programs such as a low cost medical coding and billing online program can launch your career in less time, perfect for those eager to join the workforce quickly. For advanced practice, the cheapest fnp programs online help nurses step into leadership and primary care roles with minimal financial burden.

Each of these online programs provides opportunities to enter or advance in healthcare, often at a lower cost and greater flexibility than on-campus alternatives.

Best Scientists Citing Xin Yuan Guan

Trending Scientists

Recently Published Articles